We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
26
DELISTED
Acorda Therapeutics
ACOR
| $4.49M | 0.43% |
916
+185
| +25% | +$794K |
|
|
GNCMA
27
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $4.46M | 0.43% |
324,386
+68,973
| +27% | +$827K |
|
|
CALY
28
Callaway Golf Company
CALY
$3.26B
| $4.45M | 0.42% |
578,110
+426,422
| +281% | +$3.17M |
|
|
MGI
29
DELISTED
MoneyGram International, Inc. New
MGI
| $4.44M | 0.42% |
488,822
+429,499
| +724% | +$4.27M |
|
30
Adeia
ADEA
$2.86B
| $4.41M | 0.42% |
+465,806
| New | +$3.85M |
|
|
BSTC
31
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $4.39M | 0.42% |
113,752
+34,030
| +43% | +$1.3M |
|
32
CRA International
CRAI
$1.1B
| $4.35M | 0.41% |
143,379
+97,586
| +213% | +$2.87M |
|
|
33
Century Aluminum
CENX
$4.57B
| $4.34M | 0.41% |
+178,050
| New | +$4.6M |
|
|
GFIG
34
DELISTED
GFI GROUP INC
GFIG
| $4.31M | 0.41% |
790,029
-392,485
| -33% | -$2.06M |
|
35
KBR
KBR
$4.68B
| $4.3M | 0.41% |
253,858
+216,998
| +589% | +$3.89M |
|
|
CYNO
36
DELISTED
Cynosure, Inc. Class A
CYNO
| $4.16M | 0.4% |
151,586
+12,807
| +9% | +$325K |
|
|
FOLD
37
DELISTED
Amicus Therapeutics
FOLD
| $4.09M | 0.39% |
491,191
+71,002
| +17% | +$487K |
|
|
UFS
38
DELISTED
DOMTAR CORPORATION (New)
UFS
| $4.09M | 0.39% |
101,610
+28,490
| +39% | +$1.12M |
|
|
POLY
39
DELISTED
Plantronics, Inc.
POLY
| $3.99M | 0.38% |
+75,210
| New | +$3.78M |
|
|
QLTY
40
DELISTED
QUALITY DISTR INC FLA
QLTY
| $3.87M | 0.37% |
363,880
+279,052
| +329% | +$3.17M |
|
41
Beazer Homes USA
BZH
$907M
| $3.85M | 0.37% |
+199,101
| New | +$3.64M |
|
42
Littelfuse
LFUS
$10.2B
| $3.77M | 0.36% |
+38,996
| New | +$3.62M |
|
|
IMMU
43
DELISTED
Immunomedics Inc
IMMU
| $3.76M | 0.36% |
782,459
+590,084
| +307% | +$2.33M |
|
|
PTRY
44
DELISTED
PANTRY INC (THE)
PTRY
| $3.75M | 0.36% |
101,219
-16,750
| -14% | -$452K |
|
45
Employers Holdings
EIG
$908M
| $3.75M | 0.36% |
159,527
+138,525
| +660% | +$2.89M |
|
|
RJET
46
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $3.73M | 0.36% |
255,560
-155,287
| -38% | -$1.91M |
|
47
Sanmina
SANM
$11.2B
| $3.72M | 0.35% |
158,027
-106,067
| -40% | -$2.43M |
|
|
SCMP
48
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $3.71M | 0.35% |
+259,677
| New | +$2.74M |
|
|
CRZO
49
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $3.71M | 0.35% |
+89,053
| New | +$4M |
|
|
DYAX
50
DELISTED
DYAX CORPORATION
DYAX
| $3.7M | 0.35% |
262,946
-289,866
| -52% | -$3.63M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.